Cullinan Associates Inc Bausch Health Companies Inc. Transaction History

Cullinan Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 01, 2020	SELL	$12.98 - $30.25 $620,444 - $1.45 Million	-47,800 Closed	0 $0
Q4 2019 Jan 15, 2020	SELL	$18.89 - $31.89 $3,778 - $6,378	-200 Reduced 0.42%	47,800 $1.43 Million
Q3 2019 Oct 01, 2019	BUY	$20.88 - $25.66 $20,190 - $24,813	967 Added 2.06%	48,000 $1.05 Million
Q2 2019 Jul 16, 2019	BUY	$20.52 - $26.45 $14,364 - $18,515	700 Added 1.51%	47,033 $1.19 Million
Q1 2019 Apr 30, 2019	BUY	$20.23 - $26.29 $2,023 - $2,629	100 Added 0.22%	46,333 $1.14 Million
Q3 2018 Oct 19, 2018	BUY	$20.64 - $25.67 $954,249 - $1.19 Million	46,233 New	46,233 $1.19 Million

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Cullinan Associates Inc with notifications on news.